✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (235 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
38.00
3,94,115
70.57
1,62,735
23.42
1,26,313
61.23
1,22,592
18.50
1,05,095
53.91
1,02,043
21.76
99,501
24.20
89,516
48.63
70,624
27.98
63,916
18.55
62,895
76.53
57,680
124
48,044
49.36
46,900
91.17
46,390
102
46,383
136
34,913
44.57
34,703
36.04
33,517
42.23
32,525
37.04
27,566
39.17
26,837
257
25,256
-
24,755
30.13
24,364
59.30
22,952
-
21,542
113
20,728
53.85
19,258
31.23
18,836
108
18,517
48.10
17,129
96.62
17,018
36.54
16,818
28.70
16,219
9.23
15,677
177
14,825
31.58
13,751
38.33
13,745
59.44
11,888
28.36
11,723
23.60
11,698
23.23
11,137
56.28
10,640
34.72
10,437
54.65
9,746
79.77
8,864
22.71
8,245
23.08
8,080
28.83
7,759
21.69
7,407
25.76
6,863
-
5,377
29.35
5,227
39.92
5,181
23.48
4,433
147
4,391
40.28
4,198
-
4,179
86.82
3,872
44.54
3,796
20.48
3,742
57.65
3,566
27.13
3,550
25.09
3,434
53.06
3,107
48.55
3,073
41.62
2,939
117
2,875
8.57
2,712
25.75
2,705
-
2,629
224
2,578
27.46
2,543
33.65
2,193
28.43
2,080
36.60
1,996
45.57
1,933
59.93
1,904
16.73
1,784
26.88
1,635
28.17
1,622
43.00
1,617
25.27
1,594
30.59
1,440
25.55
1,109
12.60
1,088
10.11
1,057
-
978
-
933
19.18
885
40.98
856
19.28
829
3.52
814
77.68
786
39.00
782
21.76
760
26.98
756
46.85
747
36.67
725
32.95
721
21.09
697
34.64
654
151
646
11.75
631
-
622
26.25
582
15.91
516
21.09
494
-
485
50.58
481
74.08
466
-
451
39.17
368
47.45
356
33.01
341
54.67
339
25.29
338
63.79
336
-
328
18.93
327
-
327
27.31
321
17.23
290
27.54
270
32.51
264
31.81
263
10.67
259
20.24
259
31.72
257
25.91
248
-
234
-
221
16.09
217
-
208
21.34
205
101
203
7.53
198
34.45
184
44.23
184
9.79
175
660
171
234
164
-
163
11.97
162
16.68
159
398
159
13.36
144
19.70
141
11.42
138
40.78
138
17.21
138
15.71
133
-
132
34.15
128
16.86
127
11.65
125
-
123
27.68
122
17.40
115
11.49
110
18.20
104
26.48
100
20.39
98
-
95
29.65
92
18.30
91
10.13
90
20.68
89
9.36
79
24.59
69
9.98
68
-
68
15.35
65
16.95
64
-
57
48.62
54
121
52
7.03
51
49.21
51
-
49
-
48
30.11
47
13.74
46
44.20
46
10.75
45
18.61
43
85.43
43
20.75
42
95.31
42
48.42
41
15.64
41
40.56
40
12.20
40
-
39
51.89
37
167
37
-
37
13.28
36
33.27
32
-
31
52.49
31
-
31
12.57
26
146
26
84.60
25
22.79
23
-
21
-
20
-
19
-
18
-
17
-
16
15.15
16
-
15
34.72
14
-
14
115
11
22.81
11
-
11
-
11
44.91
10
-
9
110
9
293
9
31.45
8
740
7
-
6
-
6
89.51
5
-
5
-
4
42.85
3
-
1
-
-
Showing 5 235 of 235 Show More
Market Share

    Select a Metric
    • Fermentation Based API Products - Market Share (%)
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Vaccines - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Timeline
        Watchlist
        Portfolio
        Alerts
        Research
        Stock Screener
        Market
        Raw Material